Clean Power Hydrogen PLC (AIM:CPH2) is set to raise at least £6 million through a share offering to advance its Membrane-Free Electrolyser (MFE) technology and achieve strategic milestones. The company recently cleared a significant hurdle by passing a factory acceptance test for its MFE110 unit, marking a validation of its technology with the first customer. Moving forward, CPH2 is focused on commercializing the larger MFE220 unit, with initial deployments planned for various locations including Northern Ireland Water, New Zealand’s Fabrum Solutions, and Ireland’s Hidrigin. The company has already secured contracts for these units and established license agreements with key partners to expedite global scalability. The proceeds from the fundraising will primarily support the shipping, installation, and commissioning of the MFE110 unit, as well as the finalization of the MFE220 design and deployment. Additionally, the funds will fuel CPH2’s growth strategy, which involves activating current license agreements and preparing for manufacturing scale-up by late 2026. The ultimate goal for Clean Power Hydrogen PLC is to develop a flexible and capital-efficient business model that combines in-house manufacturing with external partnerships to drive sustainable growth and enhance shareholder value.